Awakening the “guardian of genome”: reactivation of mutant p53
Author:
Funder
DST-SERB, Government of India
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Link
http://link.springer.com/article/10.1007/s00280-018-3701-x/fulltext.html
Reference90 articles.
1. Menendez D, Inga A, Resnick MA (2009) The expanding universe of p53 targets. Nat Rev Cancer 9(10):724–737
2. Goldstein I, Marcel V, Olivier M, Oren M, Rotter V, Hainaut P (2011) Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies. Cancer Gene Ther 18(1):2–11. https://doi.org/10.1038/cgt.2010.63
3. Muller PAJ, Vousden KH, Norman JC (2011) p53 and its mutants in tumor cell migration and invasion. J Cell Biol 192(2):209–218. https://doi.org/10.1083/jcb.201009059
4. Brown CJ, Cheok CF, Verma CS, Lane DP Reactivation of p53: from peptides to small molecules. Trends Pharmacol Sci 32(1):53–62. https://doi.org/10.1016/j.tips.2010.11.004
5. Stindt MH, Muller PA, Ludwig RL, Kehrloesser S, Dotsch V, Vousden KH (2015) Functional interplay between MDM2, p63/p73 and mutant p53. Oncogene 34(33):4300–4310. https://doi.org/10.1038/onc.2014.359
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. miRNAs and related genetic biomarkers according to the WHO glioma classification: From diagnosis to future therapeutic targets;Non-coding RNA Research;2024-03
2. Mutant p53R211* ameliorates inflammatory arthritis in AIA rats via inhibition of TBK1-IRF3 innate immune response;Inflammation Research;2023-11-08
3. MicroRNA‐215‐5p promotes proliferation, invasion, and inhibits apoptosis in liposarcoma cells by targeting MDM2;Cancer Medicine;2023-05-03
4. The Competition of Yin and Yang: Exploring the Role of Wild-Type and Mutant p53 in Tumor Progression;Biomedicines;2023-04-17
5. Targeting p53 pathways: mechanisms, structures, and advances in therapy;Signal Transduction and Targeted Therapy;2023-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3